SREBF1 and metabolic disease: Research indicates that dysregulation of lipid metabolism, along with the excessive accumulation of lipids in non-adipose tissues due to the upregulation of srebf1, is implicated in the development of metabolic disorders, including obesity, insulin resistance, and fatty liver disease (40).